Thakker Janki, Khaliq Isna, Ardeshna Nelish S, Lavie Carl J, Oktay Ahmet Afsin
Department of Internal Medicine, Division of Cardiology, Rush University Medical Center, 1717 W. Congress Parkway, Kellogg Building 316, Chicago, IL, 60612, USA.
Ochsner Clinical School, John Ochsner Heart and Vascular Institute, The University of Queensland School of Medicine, New Orleans, LA, USA.
Curr Diab Rep. 2025 Jun 7;25(1):35. doi: 10.1007/s11892-025-01592-4.
The "obesity paradox" describes the counterintuitive observation that overweight and mildly obese individuals with cardiovascular disease (CVD) may have better outcomes than those with normal weight. This paradox is particularly intriguing in patients with type-2 diabetes (T2D), where obesity is a well-established risk factor for cardiometabolic complications.
Evidence from some epidemiological studies suggested an obesity paradox in mortality risk among patients with T2D. However, confounding factors may influence this association, including reverse causality, differences in risk factor profiles, and adipose tissue distribution. Recent research also questions the reliance on body mass index as an accurate measure of metabolic health, emphasizing the role of alternative anthropometric indices. This review critically evaluates the evidence for the obesity paradox in T2D, explores potential mechanistic explanations, and discusses clinical implications. Understanding the complex interaction between diabetes and obesity in CVD risk is essential for refining obesity management strategies in individuals with T2D and CVD.
“肥胖悖论”描述了一种与直觉相悖的现象,即患有心血管疾病(CVD)的超重和轻度肥胖个体可能比体重正常者预后更好。这种悖论在2型糖尿病(T2D)患者中尤为引人关注,因为肥胖是公认的心血管代谢并发症危险因素。
一些流行病学研究的证据表明,T2D患者的死亡风险存在肥胖悖论。然而,混杂因素可能会影响这种关联,包括反向因果关系、危险因素谱差异和脂肪组织分布。近期研究还对将体重指数作为代谢健康的准确衡量指标提出质疑,强调了替代人体测量指标的作用。本综述批判性地评估了T2D中肥胖悖论的证据,探讨了潜在的机制解释,并讨论了临床意义。了解糖尿病与肥胖在CVD风险中的复杂相互作用对于优化T2D和CVD个体的肥胖管理策略至关重要。